Early Access Program With Arimoclomol in US Patients With NPC

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

ClinicalTrials.gov Identifier: NCT04316637

Expanded Access Status : Available

First Posted : March 20, 2020

Last Update Posted : July 27, 2021

Sponsor:

Information provided by (Responsible Party):

Orphazyme

Study Details
Tabular View
Disclaimer
How to Read a Study Record

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Expanded Access Status :	Available
Primary Completion Date :	No date given
Study Completion Date :	No date given

To Top